US Oncology Holdings, Inc. Watch

EX-10.2

from 8-K 16 pages US Oncology Holdings, Inc. Amended and Restated Director Stock Option and Restricted Stock Award Plan October 1, 2009

12/34/56

EX-10.1

from 8-K 2 pages Amendment

12/34/56

EX-10.2

from 8-K 43 pages Guarantee and Collateral Agreement Dated as of August 26, 2009, Among US Oncology Holdings, Inc., US Oncology, Inc., the Subsidiaries of US Oncology, Inc. Identified Herein and Deutsche Bank Trust Company Americas, as Collateral Agent

12/34/56

EX-10.4

from 10-K 11 pages Employment Agreement

12/34/56

EX-10.5

from 10-Q 2 pages US Oncology Holdings, Inc. Unit Award Agreement Under the 2008 Long-Term Cash Incentive Plan

12/34/56

EX-10.2

from 8-K 18 pages US Oncology Holdings, Inc. 2008 Long-Term Cash Incentive Plan US Oncology Holdings, Inc. 2008 Long-Term Cash Incentive Plan

12/34/56

EX-10.1

from 8-K 22 pages US Oncology Holdings, Inc. 2004 Equity Incentive Plan

12/34/56

EX-10.1

from 8-K 38 pages US Oncology Holdings, Inc. $425,000,000 Senior Unsecured Floating Rate Toggle Notes Due 2012 Purchase Agreement

12/34/56

EX-10.3

from 8-K 24 pages Amended and Restated Registration Rights Agreement

12/34/56

EX-10.2

from 8-K 31 pages Amended and Restated Stockholders Agreement

12/34/56

EX-10.1

from 8-K 34 pages Stock Purchase Agreement US Oncology Holdings, Inc. December 21, 2006

12/34/56

EX-10.1

from 8-K 14 pages Incremental Facility Amendment and Amendment No. 3 Dated as of November 15, 2005

12/34/56